Author:
Branscome Heather,Khatkar Pooja,Al Sharif Sarah,Yin Dezhong,Jacob Sheela,Cowen Maria,Kim Yuriy,Erickson James,Brantner Christine A.,El-Hage Nazira,Liotta Lance A.,Kashanchi Fatah
Abstract
AbstractHIV-1 remains an incurable infection that is associated with substantial economic and epidemiologic impacts. HIV-associated neurocognitive disorders (HAND) are commonly linked with HIV-1 infection; despite the development of combination antiretroviral therapy (cART), HAND is still reported to affect at least 50% of HIV-1 infected individuals. It is believed that the over-amplification of inflammatory pathways, along with release of toxic viral proteins from infected cells, are primarily responsible for the neurological damage that is observed in HAND; however, the underlying mechanisms are not well-defined. Therefore, there is an unmet need to develop more physiologically relevant and reliable platforms for studying these pathologies. In recent years, neurospheres derived from induced pluripotent stem cells (iPSCs) have been utilized to model the effects of different neurotropic viruses. Here, we report the generation of neurospheres from iPSC-derived neural progenitor cells (NPCs) and we show that these cultures are permissive to retroviral (e.g. HIV-1, HTLV-1) replication. In addition, we also examine the potential effects of stem cell derived extracellular vesicles (EVs) on HIV-1 damaged cells as there is abundant literature supporting the reparative and regenerative properties of stem cell EVs in the context of various CNS pathologies. Consistent with the literature, our data suggests that stem cell EVs may modulate neuroprotective and anti-inflammatory properties in damaged cells. Collectively, this study demonstrates the feasibility of NPC-derived neurospheres for modeling HIV-1 infection and, subsequently, highlights the potential of stem cell EVs for rescuing cellular damage induced by HIV-1 infection.
Publisher
Springer Science and Business Media LLC
Reference158 articles.
1. UNAIDS. Global HIV & AIDS statistics — 2019 fact sheet. PDF at https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.
2. Saylor, D. et al. HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nat. Rev. Neurol. 12, 234–248 (2016).
3. Chen, M. F., Gill, A. J. & Kolson, D. L. Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism. Curr. Opin. HIV AIDS. 9, 559–564 (2014).
4. Eggers, C. et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J. Neurol. 264, 1715–1727 (2017).
5. Ferrell, D. & Giunta, B. The impact of HIV-1 on neurogenesis: implications for HAND. Cell Mol. Life Sci. 71, 4387–4392 (2014).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献